Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C09DA01	HYZAAR	B	Losartan potassium - 100mg, Hydrochlorothiazide - 12.5mg		Tablet	1,740,596 L.L
L04AD02	ADVAGRAF	B	Tacrolimus monohydrate - 3mg	3mg	Capsule, prolonged release	68,645,618 L.L
N02CC01	IMIGRAN	B	Sumatriptan (succinate) - 100mg	100mg	Tablet, film coated	616,824 L.L
N05AX08	RISPERDAL	B	Risperidone - 1mg	1mg	Tablet, film coated	306,396 L.L
A08AB01	XENICAL	B	Orlistat - 120mg	120mg	Capsule	4,036,903 L.L
C07AB02	BETALOC ZOK	B	Metoprolol succinate - 50mg	50mg	Tablet, controlled release	491,846 L.L
D11AX01	REGAINE FOAM FOR MEN	B	Minoxidil - 5%		Foam	1,370,719 L.L
H01CB02	SANDOSTATIN	B	Octreotide - 0.1mg/ml	0.1mg/ml	Injectable solution	1,038,790 L.L
L04AD02	ADVAGRAF	B	Tacrolimus monohydrate - 1mg	1mg	Capsule, prolonged release	25,729,044 L.L
N06DX01	EBIXA	B	Memantine - 20mg	20mg	Tablet, film coated	4,004,651 L.L
B03AB09	FERPLEX	B	Iron trivalent (ferric proteinsuccinylate) - 800mg	800mg	Solution	1,202,739 L.L
D11AX01	REGAINE FOAM FOR MEN	B	Minoxidil - 5%		Foam	3,090,838 L.L
H01CB02	SANDOSTATIN LAR	B	Octreotide (acetate) - 20mg	20mg	Injectable powder for suspension+diluent	36,504,302 L.L
J02AC01	DIFLUCAN	B	Fluconazole - 50mg	50mg	Capsule	622,199 L.L
L04AD02	ADVAGRAF	B	Tacrolimus monohydrate - 5mg	5mg	Capsule, prolonged release	85,485,667 L.L
M03BX02	SIRDALUD	B	Tizanidine HCl - 2mg	2mg	Tablet	631,148 L.L
N02CC01	IMIGRAN	B	Sumatriptan (succinate) - 50mg	50mg	Tablet, film coated	378,964 L.L
S01HA02	ANESTOCIL	B	Oxybuprocaine HCl (Benoxinate HCl) - 0.4%	0.4%	Drops solution	442,124 L.L
B03AC	VENOFER I.V.	B	Iron (sucrose) - 100mg/5ml	100mg/5ml	Injectable concentrated solution	3,594,779 L.L
C07AB02	BETALOC ZOK	B	Metoprolol succinate - 25mg	25mg	Tablet, controlled release	219,046 L.L
H01CB02	SANDOSTATIN LAR	B	Octreotide (acetate) - 30mg	30mg	Injectable powder for suspension+diluent	54,757,132 L.L
L04AD02	ADVAGRAF	B	Tacrolimus monohydrate - 0.5mg	0.5mg	Capsule, prolonged release	13,297,758 L.L
M03BX02	SIRDALUD	B	Tizanidine HCl - 4mg	4mg	Tablet	826,175 L.L
C09DA03	CO-DIOVAN	B	Valsartan - 80mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	602,041 L.L
H01CB03	SOMATULINE AUTOGEL	B	Lanreotide (acetate) - 90mg	90mg	Injectable solution	48,383,450 L.L
L04AX01	IMURAN	B	Azathioprine - 50mg	50mg	Tablet	2,030,546 L.L
M03BX04	MYDOCALM	B	Tolperisone - 150mg	150mg	Tablet, film coated	839,902 L.L
N05AX08	RISPERDAL	B	Risperidone - 1mg/ml	1mg/ml	Solution	1,377,439 L.L
C07AB03	TENORMIN	B	Atenolol - 50mg	50mg	Tablet, film coated	393,746 L.L
C10AB05	LIPANTHYL 200 M	B	Fenofibrate - 200mg	200mg	Capsule	1,072,878 L.L